Publications - Page 13 sur 43 - RespiFIL - Filière de santé des maladies respiratoires rares

Voici les publications scientifiques relatives aux maladies respiratoires rares auxquelles les membres de la filière ont contribué, classées par groupes de pathologies (depuis juillet 2021).

Hypertension pulmonaire (HTP) 31/08/23
Patients’ perceptions on clinical trials outcomes in pulmonary arterial hypertension therapy.

Mai V, Gosselin C, Tremblay É, Rompré G, Lajoie AC, Weatherald J, Lega JC, Bonnet S, Provencher S.

Thorax. 2023 Jul;78(7):721-725.
Hypertension pulmonaire (HTP) 31/08/23
The role of TAPSE/sPAP ratio in predicting pulmonary hypertension and mortality in the systemic sclerosis EUSTAR cohort.

Colalillo A, Hoffmann-Vold AM, Pellicano C, Romaniello A, Gabrielli A, Hachulla E, Smith V, Simeón-Aznar CP, Castellví I, Airò P, Truchetet ME, Siegert E, Distler O, Rosato E; EUSTAR collaborators.

Autoimmun Rev. 2023 Apr;22(4):103290.
Hypertension pulmonaire (HTP) 31/08/23
Hemodynamic characteristics in patients with pulmonary hypertension and chronic obstructive pulmonary disease: A retrospective monocentric cohort study.

Thoré P, Staentzel J, Valentin S, Guillaumot A, Selton-Suty C, Gomez E, Chabot F, Chaouat A.

Respir Med Res. 2023 Jun;83:101008.
Hypertension pulmonaire (HTP) 31/08/23
AMPK activation by metformin protects against pulmonary hypertension in rats and relaxes isolated human pulmonary artery.

Abdelazeem H, Tu L, Thuillet R, Ottaviani M, Boulfrad A, Beck T, Senbel A, Mani S, Castier Y, Guyard A, Tran-Dinh A, El-Benna J, Longrois D, Silverstein AM, Guignabert C, Norel X.

ur J Pharmacol. 2023 May 5;946:175579.
Hypertension pulmonaire (HTP) 31/08/23
Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: a clinical consensus statement of the ESC working group on pulmonary circulation and right ventricular function.

Lang IM, Andreassen AK, Andersen A, Bouvaist H, Coghlan G, Escribano-Subias P, Jansa P, Kopec G, Kurzyna M, Matsubara H, Meyer BC, Palazzini M, Post MC, Pruszczyk P, Räber L, Roik M, Rosenkranz S, Wiedenroth CB, Redlin-Werle C, Brenot P.

Eur Heart J. 2023 Aug 1;44(29):2659-2671.
Hypertension pulmonaire (HTP) 31/08/23
Pulmonary arterial compliance and exercise capacity after balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension.

Sermet R, Piliero N, Guillien A, Madoun S, Doutreleau S, Salvat M, Finas M, Thony F, Vautrin E, Bouvaist H, Degano B.

ERJ Open Res. 2023 Mar 27;9(2):00590-2022.
Hypertension pulmonaire (HTP) 31/08/23
Diastolic ventricular function in persistent pulmonary hypertension of the newborn.

Le Duc K, Rakza T, Baudelet JB, Boukhris MR, Mur S, Houeijeh A, Storme L.

Front Pediatr. 2023 Jun 26;11:1175178.
Hypertension pulmonaire (HTP) 31/08/23
Impact of targeted pulmonary arterial hypertension therapies in severe pulmonary hypertension in chronic lung diseases.

Naud R, Bermudez J, Resseguier N, Nieves A, Coltey B, Dufeu N, Gautier C, Trigui Y, Laine M, Coiffard B, Reynaud-Gaubert M.

ERJ Open Res. 2023 Aug 21;9(4):00027-2023.
Hypertension pulmonaire (HTP) 31/08/23
Targeting Mitochondrial Metabolic Dysfunction in Pulmonary Hypertension: Toward New Therapeutic Approaches?

Riou M, Enache I, Sauer F, Charles AL, Geny B.

Int J Mol Sci. 2023 May 31;24(11):9572.
Hypertension pulmonaire (HTP) 31/08/23
[Hepatopulmonary syndrome].

Sayadi A, Duhaut L, Robert F, Savale L, Coilly A.

Rev Med Interne. 2023 Mar 31:S0248-8663(23)00113-3.

FILTRER :

Par mot clé

Par maladies

Réinitialiser les filtres

Patients’ perceptions on clinical trials outcomes in pulmonary arterial hypertension therapy.

The role of TAPSE/sPAP ratio in predicting pulmonary hypertension and mortality in the systemic sclerosis EUSTAR cohort.

Hemodynamic characteristics in patients with pulmonary hypertension and chronic obstructive pulmonary disease: A retrospective monocentric cohort study.

AMPK activation by metformin protects against pulmonary hypertension in rats and relaxes isolated human pulmonary artery.

Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: a clinical consensus statement of the ESC working group on pulmonary circulation and right ventricular function.

Pulmonary arterial compliance and exercise capacity after balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension.

Diastolic ventricular function in persistent pulmonary hypertension of the newborn.

Impact of targeted pulmonary arterial hypertension therapies in severe pulmonary hypertension in chronic lung diseases.

Targeting Mitochondrial Metabolic Dysfunction in Pulmonary Hypertension: Toward New Therapeutic Approaches?

[Hepatopulmonary syndrome].